poisar

Stock

Johnson & Johnson JNJ

$263.41+1.55%

Overview

JNJ market data

Price History

JNJ price chart

Valuation & Profitability

Twelve Data
P/E (TTM)
29.22
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$11.03
Diluted earnings per share over the trailing twelve months.
Beta
0.23
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
209.7%
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$164.23 – $269.43
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $614.6K · P/B 6.13 · P/S 6.28.

Company news

10 captured
Electrosurgery Market Projected to Reach $11.59 Billion by 2031 as Demand for Minimally Invasive Procedures Rises - Analysis by Product, Surgery, End User and RegionGlobenewswire Inc · Jul 24, 2026, 3:15 PM
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing ItThe Motley Fool · Jul 24, 2026, 3:15 PM
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026?The Motley Fool · Jul 23, 2026, 8:15 PM
Palisade Bio Analyst Sees Lead Drug Can Potentially Bridge Gap in Ulcerative ColitisBenzinga · Jul 23, 2026, 6:06 PM
Which Is the Better Healthcare ETF: First Trust's High-Conviction FBT or Vanguard's Low-Cost VHT?The Motley Fool · Jul 23, 2026, 1:15 PM
Johnson & Johnson Announces Topline Results From Phase 3 MonumenTAL-6 Study Evaluating TECVAYLI + TALVEY In Adult Patients With Multiple Myeloma; Study Demonstrated Statistically Significant And Clinically Meaningful Improvements In Progression-Free Survival And Overall SurvivalBenzinga · Jul 23, 2026, 12:39 PM
Which ETF Is Healthier for Your Portfolio: Vanguard Health Care ETF or iShares Pharmaceuticals ETF?The Motley Fool · Jul 22, 2026, 9:15 PM
As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026?The Motley Fool · Jul 22, 2026, 8:15 PM
Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsightGlobenewswire Inc · Jul 22, 2026, 5:15 PM
FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery SystemBenzinga · Jul 22, 2026, 5:08 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock